Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
7,232
Total Claims
$689K
Drug Cost
1,087
Beneficiaries
$634
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 2,621 Pain Management providers
+58%
Opioid rate vs peers
65.1% vs 41.3% avg
+59%
Cost per patient vs peers
$634 vs $399 avg
+141%
Brand preference vs peers
9.0% vs 3.8% avg
Opioid Prescribing
65.1%
Opioid Rate
4,710
Opioid Claims
$502K
Opioid Cost
18.5%
Long-Acting Rate
This provider's opioid prescribing rate of 65.1% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 653 claims · $405K
Generic: 6,579 claims · $283K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Buprenorphine Hcl | 174 | $145K |
| Buprenorphine | 212 | $85K |
| Oxycodone Hcl/Acetaminophen | 785 | $68K |
| Hydrocodone/Acetaminophen | 2,140 | $65K |
| Suvorexant | 68 | $30K |
| Oxycodone Myristate | 44 | $26K |
| Buprenorphine | 26 | $21K |
| Oxycodone Hcl | 47 | $20K |
| Tramadol Hcl | 97 | $11K |
| Tapentadol Hcl | 18 | $10K |
| Hydrocodone Bitartrate | 17 | $9,967 |
| Pregabalin | 376 | $9,749 |
| Oxycodone Hcl | 428 | $8,799 |
| Linaclotide | 16 | $8,776 |
| Buprenorphine Hcl/Naloxone Hcl | 33 | $8,369 |
Prescribing Profile
38
Unique Drugs
12.0
Anomaly Score
Patient Profile
66
Avg Age
61%
Female
1.79
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About